India Approves Qdenga Dengue Vaccine Amid Rising Cases

India has approved the Qdenga vaccine to combat rising dengue fever cases, particularly in high-risk regions like Karnataka. Medical experts emphasize that the vaccine, combined with mosquito control, is a vital tool for reducing hospitalizations.
Bengaluru: The Drugs Controller General of India (DCGI) has granted approval for Qdenga, a dengue vaccine aimed at lowering the risk of infection, severe disease, and hospitalisation. Local medical professionals have praised the approval as a major advancement in public health, particularly during peak periods of dengue transmission.
Get the full story
Sign up for Headlinne to unlock AI insights, political bias analysis, and your personalized news feed.
Create free accountAlready have an account? Sign in